An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism

Trial Profile

An Open-Label Pilot Study of Pregnenolone in the Treatment of Individuals With Autism

Completed
Phase of Trial: Phase II

Latest Information Update: 03 Apr 2017

At a glance

  • Drugs Pregnenolone (Primary)
  • Indications Autistic disorder
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Dec 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 13 Jan 2014 Planned End Date changed from 1 Dec 2013 to 1 Dec 2014 according to ClinicalTrial.gov.
    • 03 Jul 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top